Experimental pill achieves complete cancer remission in 18 people with aggressive leukemia
The new drug, called revumenib, has completely eliminated cancer in a third of the participants in a long-awaited clinical study from the University of Texas.
Science & academia
Safe, effective new procedure to surgically treat common arrhythmia
Called pulsed field ablation, the technique uses electrical pulses to create tiny holes in the membranes of heart muscle cells, causing the cells to die.
Breakthrough drug works against all the main types of primary bone cancer
The drug, developed by researchers at the U.K.’s University of East Anglia, increases survival rates by 50% without the need for surgery or chemotherapy.
Researchers cure toddler of deadly metachromatic leukodystrophy (MLD) for first time in history
A British girl born with a rare and deadly genetic condition is expected to live a long and normal life after becoming the world’s first person to be cured with the help of a revolutionary gene therapy.
World’s largest four day work week trial deemed a success
An incredible 92 percent of companies said they would continue to have employees work four days.
26 Australian species no longer need threatened listing
A new analysis has found that the population size and distributions of 14 mammal, eight bird, two frog, one reptile and one fish species in Australia had sufficiently improved to no longer meet listing criteria.
Brain circuit breakthrough paves way for opioid addiction treatments
Scientists at the Texas A&M University have identified a specific circuit in the brain from which many negative emotional states stem from during fentanyl withdrawal and could be the reason many chronic users relapse.
Researchers can now pull green hydrogen directly from seawater
University of Adelaide researchers claim to have made clean hydrogen fuel from seawater without pre-treatment. Their findings could eventually provide cheaper green energy production from a near-limitless source to coastal areas.
First vaccine to target deadly fungal infections passes preclinical tests
Fungal infections cause more than 1.5 million deaths annually and cost billions. A new vaccine from the University of Georgia could be the first clinically approved immunization to protect against them.
U.K. scientists discover method to reduce steelmaking’s CO2 emissions by 90%
The iron and steel industry is a major cause of greenhouse gasses, accounting for 9% of global emissions.